Biotech startups are being urged to pitch for a new accelerator designed to advance solutions for diseases of the central nervous system (CNS).
The online marketplace for life sciences, Scientist.com, and the Brain and Spine Institute incubator, iPEPS-ICM, have teamed up to launch the new call – open to early stage biotechs from around the world – to pitch their pioneering ‘novel approaches for fighting CNS diseases’.
“In the field of diseases of the nervous system, the probability that drug candidates reach the market is only 7%, compared with an average of 15%. This outcome makes it very difficult for young enterprises to establish themselves in biotechnology. This startup competition is here to help young entrepreneurs to develop their innovation in the best environment, with 700 researchers at The Brain and Spine Institute, 25 state-of-the-art platforms, a LivingLab and a FabLab,” said Julien Elric, iPEPS incubator manager.
The winner will get six months free rent at iPEPS’ facilities located in Paris and $10K in research support from Scientist.com. Three months rent and $6K will go to the runner up.
Applications need to be submitted between 28 May to 16 July.